FDA.reportPublic FDA data

Obagi-C C-Rx System Normal-Dry Skin Intervention

Product NDC
62032-922
Requested package NDC
62032-922-01
11-digit product format
620320922
Labeler code
62032
Product ID
62032-922_379fa44a-bdd2-4048-8b45-1fec370a3788
Type
HUMAN OTC DRUG
Nonproprietary name
HYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDE
Dosage form
KIT
Labeler
Obagi Cosmeceuticals LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2019-12-02
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Obagi-C C-Rx System Normal-Dry Skin Intervention
Listing expiration
2026-12-31

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
197795Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
e9d8488f-b902-45f4-a6d6-c6eb393c8f08Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
1681bc73-b05f-12c3-1075-382ae39f449cProduct name120140508
85490a6b-2306-6bf2-c51b-eb63537dc2daProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62032-105-36Obagi-C C-Rx System Normal-Dry Skin Intervention57 g in 1 BOTTLE, PLASTICCREAM57 g40 mg in 1g3
62032-106-10Obagi-C C-Rx System Normal-Dry Skin Intervention30 mL in 1 BOTTLE, GLASSSOLUTION30 mL40 mg in 1mL3
62032-106-10Obagi-C C-Rx System Normal-Dry Skin Intervention1 in 1 CARTONSOLUTION40 mg in 1mL3
62032-811-09Obagi-C C-Rx System Normal-Dry Skin Intervention85 g in 1 TUBELOTION85 g15.6 g in 100g3
62032-811-09Obagi-C C-Rx System Normal-Dry Skin Intervention1 in 1 CARTONLOTION6.2 g in 100g3
62032-922-01Obagi-C C-Rx System Normal-Dry Skin Intervention1 in 1 BAGKIT13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Obagi-C C-Rx System Normal-Dry Skin InterventionHYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDEObagi Cosmeceuticals LLCe9d8488f-b902-45f4-a6d6-c6eb393c8f082025-11-13WarningsExact identifier
ndc (package): 62032-922-01
ndc (product): 62032-922
ndc11 (package): 62032092201

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
197795hydroquinone 4 % Topical CreamPSNe9d8488f-b902-45f4-a6d6-c6eb393c8f083
197795hydroquinone 40 MG/ML Topical CreamSCDe9d8488f-b902-45f4-a6d6-c6eb393c8f083
197795hydroquinone 4 % Topical CreamSYe9d8488f-b902-45f4-a6d6-c6eb393c8f083

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
62032-922-01620320922011 KIT in 1 BAG (62032-922-01) * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 177 mL in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC (62032-105-36) * 1 BOTTLE, GLASS in 1 CARTON (62032-106-10) / 30 mL in 1 BOTTLE, GLASS1 kit2025-06-25NoNoCurrent